Recreational cannabis could soon be coming to the Keystone State. That's if Pennsylvania lawmakers Daylin Leach and Sharif Street can muster enough support for their latest proposal. The state senators introduced Senate Bill 350 on Oct. 15. The bill would allow for both home delivery and the automatic expungement of many previous criminal convictions related to marijuana. The bill's supporters estimate it will generate $500 million in tax revenue within 12 months.

Gov. Tom Wolf recently changed his position, announcing he now supports legalization. Just days after the bill was introduced, Wolf met with Gov. Andrew Cuomo (New York), Gov. Phil Murphy (New Jersey), and Gov. Ned Lamont (Connecticut) to discuss coordinating marijuana across the Northeast.

"We need regulation, we need to make sure we're protecting public health, public safety. But that's regulation, not prohibition," Wolf said. "It's also really important that we work together as a region to make sure that we're on the same page."

In contrast to the approach of many other states, Senate Bill 350 contains a provision allowing homegrower permits for personal use. The bill also envisions "use lounges" where individuals can legally consume marijuana brought from outside the establishment.

"An end to the prohibition of cannabis is overdue," Street said in a press release. "It is time for us to join the emerging cannabis economy with the legalization of the adult use of cannabis in Pennsylvania, which should not be a crime when responsibly used by adults nor mandate medical oversight."

"Pennsylvania's cannabis policy is cruel, irrational and expensive," Leach said. "Prohibition has destroyed countless lives and has cost taxpayers millions.

"We need to stop arresting our kids and funding violent drug cartels," Leach continued. "This is going to be a tough battle, but so was passing medical marijuana. We did that, and we'll do this too. The stakes are too high for us to fail."

Leach released a press release identifying several key points in the proposal:

  • A system of permits for industry participants with low barriers to entry in order to allow people with limited resources to enter the cannabis industry.
  • Automatic expungement of previous criminal convictions, dismissal of pending charges and commutation of sentences.
  • Tax revenue collected pursuant to the bill—an estimated $500 million in the first full fiscal year of operation—will be appropriated to school districts using the 2016 fair funding formula (Act 35). School districts have total discretion over the funding; they may choose to invest in their schools, hire more teachers, or even provide local tax relief to homeowners in their districts.
  • Use of cannabis will be permitted by adults over 21 years of age.
  • Home delivery of cannabis will be permitted. The bill's language allows deliverers, who may start their own company or work for dispensaries, to use any form of transportation—from cars to bicycles to public transportation—to deliver cannabis.
  • People will be permitted to grow up to 10 plants for personal use in their own homes.

While public support for legalization appears to be increasing, Senate Bill 350 likely faces an uphill battle. On the other side of the Delaware River, New Jersey's much-anticipated legalization bill never even made it to the floor for a vote. Despite widespread optimism and strong support from the governor, New Jersey cannabis reform advocates now appear resigned to wait for a ballot initiative.

The political landscape is even less favorable for reform in Pennsylvania. Across the nation, many more states have legalized cannabis through ballot initiatives than legislative action. In Pennsylvania, previous attempts to legalize recreational cannabis have failed due to a lack of bipartisan support.

|

Pennsylvania Expands Medical Marijuana Program

In July, Pennsylvania significantly expanded its medical marijuana program. The state now includes anxiety and Tourette's on the list of qualifying conditions for enrollment. The move by the Pennsylvania Health Department now allows medical marijuana for conditions beyond cancer, epilepsy, seizures, post-traumatic stress disorder and terminal illness. Similar decisions in other states have led to rapid increases in enrollment.

Pennsylvania has nearly 116,000 patients certified for participation in its medical marijuana program. The program is relatively new, coming online in February 2018.

"The first year that the state's medical marijuana program has been operational tells us that this program is working to help Pennsylvanians in need of this medication," Wolf said. "Patients are realizing the benefits and there has been steady, positive progress that I am pleased to report."

In its first full year, Pennsylvania collected $2 million in tax revenue from growers and processors. Dispensaries reported $132 million in sales. The program has also expanded to allow patients to purchase marijuana in dried leaf form. Initially only pills, liquids or topical ointments were permitted.

"Our goal for the next year and beyond is to increase the number of grower/processors and dispensaries operating, to register even more physicians and to continue the growth of our scientific, medically based program," said Department of Health Secretary Dr. Rachel Levine.

Pennsylvania's medical marijuana program is noteworthy for its promotion of scientific testing. As part of the program, the state certifies eight academic clinical research centers. The mission of the clinical program is to conduct, "Research on the therapeutic or palliative efficacy of medical marijuana limited to the serious medical conditions defined by the act and the temporary regulations." The state also has four approved laboratories for quality testing and sampling.

Patrick McKnight is a law clerk at Wilson Elser Moskowitz Edelman & Dicker. He is a J.D./MBA candidate at Rutgers University and will graduate in 2020 with a certificate in corporate and business law. He focuses his practice on defense litigation, corporate law, design and professional liability, construction defect liability, personal injury defense and cannabis law.